Nectar Lifescience Ltd
Next 500 2024
+ 10 More
+ 10 More
Share
Share
OVERVIEW
FINANCIALS
About
Nectar Lifesciences Limited (NLL) is known for manufacturing cephalosporin antibiotics and medicines. Its journey began as a small active pharmaceutical ingredients (API) producer and has now transformed into being one of the leading players in the anti-infective therapeutic area. Its major business revolves around the manufacturing of APIs, formulations, and empty hard gelatin capsules. With the support of 11 manufacturing facilities in Punjab and Himachal Pradesh, NLL is able to serve and save lives in more than 45 countries. As per Bio-Spectrum Asia Pacific in 2016, Nestar Lifesciences is among the top 40 forerunners in the biopharmaceutical industry in the Asia-Pacific region.
Incorporation Year: 1995
Headquarters: Chandigarh
Top Management: Saniv Goyal
Industry: Pharma
Website: www.neclife.com
Featured In Fortune India Ranking
Fortune 500 India
#443(2020)
#412(2019)
#497(2014)
#487(2013)
#443(2020)#412(2019)#497(2014)#487(2013)
Next 500 India
#357(2024)#186(2023)#119(2022)#19(2019)#42(2018)#3(2017)#2(2016)
#357(2024)#186(2023)#119(2022)#19(2019)#42(2018)#3(2017)#2(2016)
Financial Data 2024
Revenue
1,739
(INR Cr)
Net Operating Income
1,684
(INR Cr)
Assets
1,713
(INR Cr)
Profit
5
(INR Cr)
Net Worth
1,069
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1739 8.1% | 1608 -3.4% | 1664 15.4% | 1443 -39.3% | 2375 -16.4% | 2839 48.5% | 1912 15.3% | 1658 -2.8% | 1706 0.8% | 1692 -0.9% | 1708 0.1% | 1707 16.8% | 1461 26.2% | 1158 28.5% | 901 3.7% | 869 - |
| Net Operating Income (INR Cr) | 1684 10.53% | 1524 -8.70% | 1669 8.13% | 1543 -34.78% | 2366 -14.97% | 2783 48.32% | 1876 14.15% | 1644 -1.91% | 1676 1.95% | 1644 0.33% | 1638 0.74% | 1626 23.85% | 1313 23.64% | 1062 25.57% | 846 16.19% | 728 -1.08% |
| Profit (INR Cr) | 5 - | -24 - | 25 - | -73 - | 32 -33.2% | 48 -8.9% | 52 -5.6% | 55 2.0% | 54 -18.1% | 66 6.7% | 62 -27.6% | 86 17.1% | 73 -29.7% | 104 12.9% | 92 74.2% | 53 - |
| Assets (INR Cr) | 1713 -6.1% | 1826 -6.7% | 1956 -1.0% | 1976 2.6% | 1926 -5.2% | 2031 -0.5% | 2041 6.7% | 1913 -1.4% | 1940 1.9% | 1904 6.3% | 1791 2.3% | 1752 -4.4% | 1833 33.5% | 1373 12.4% | 1222 21.2% | 1008 - |
| Net Worth (INR Cr) | 1069 0.4% | 1065 -2.1% | 1088 2.4% | 1062 -6.5% | 1136 2.8% | 1105 4.4% | 1059 5.2% | 1007 5.5% | 954 -0.4% | 958 3.3% | 927 6.9% | 868 10.6% | 784 8.8% | 721 16.2% | 621 104.6% | 303 6.8% |
| Employee Cost (INR Cr) | 82 8.7% | 75 4.5% | 72 1.9% | 71 -9.7% | 78 2.2% | 77 2.5% | 75 -1.2% | 76 -3.6% | 78 33.0% | 59 22.9% | 48 5.1% | 46 3.9% | 44 30.0% | 34 16.7% | 29 11.0% | 26 - |
| Interest Cost (INR Cr) | 87 | 79 | 79 | 112 | 126 | 148 | 115 | 117 | 123 | 126 | 138 | 115 | 115 | 74 | 60 | 50 |
| Cash & Bank Balance (INR Cr) | 20 | 18 | 18 | 26 | 21 | 21 | 9 | 13 | 37 | 33 | 10 | 6 | 26 | 33 | 35 | 34 |
| Total Debt (INR Cr) | 636 | 754 | 860 | 903 | 779 | 903 | 955 | 878 | 962 | 925 | 858 | 879 | 1043 | 648 | 601 | 704 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 0.3% | - | 1.5% | - | 1.3% | 1.7% | 2.7% | 3.3% | 3.2% | 3.9% | 3.6% | 5.0% | 5.0% | 9.0% | 10.2% | 6.1% |
| Profit As % Of Assets | 0.3% | - | 1.3% | - | 1.7% | 2.3% | 2.6% | 2.9% | 2.8% | 3.5% | 3.5% | 4.9% | 4.0% | 7.6% | 7.6% | 5.3% |
| Profit As % Of Networth | 0.5% | - | 2.3% | - | 2.8% | 4.3% | 4.9% | 5.5% | 5.7% | 6.9% | 6.7% | 9.9% | 9.3% | 14.5% | 14.9% | 17.5% |
| Interest Cost to EBITDA % | 57.5% | 150.0% | 49.7% | 133.8% | 57.3% | 56.1% | 48.8% | 52.3% | 51.7% | 47.1% | 47.8% | 39.8% | 46.4% | 32.6% | 30.9% | 36.0% |
| Debt to Equity Ratio | 0.59 | 0.71 | 0.79 | 0.85 | 0.69 | 0.82 | 0.90 | 0.87 | 1.01 | 0.97 | 0.93 | 1.01 | 1.33 | 0.90 | 0.97 | 2.32 |
| RONW | 0.5% | - | 1.7% | - | 2.8% | 4.4% | 5.1% | 5.6% | 5.7% | 7.0% | 6.9% | 10.4% | 9.7% | 15.5% | 20.0% | 18.0% |
| ROCE | 6.0% | -0.2% | 5.3% | 2.7% | 8.3% | 10.2% | 9.0% | 9.6% | 9.7% | 11.4% | 12.2% | 12.9% | 12.5% | 15.0% | 15.8% | 12.8% |